Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer
Kei Kudo(National Institutes of Health), Nobuhiro Tanuma(Tohoku University)
Cited by 16
Related Papers
Nuclear Inhibitor of Protein Phosphatase-1 (NIPP1) Directs Protein Phosphatase-1 (PP1) to Dephosphorylate the U2 Small Nuclear Ribonucleoprotein Particle (snRNP) Component, Spliceosome-associated Protein 155 (Sap155)
|Journal of Biological Chemistry|2008|55
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer
|Cancer Gene Therapy|2024|10
Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer
|Cell Death and Disease|2025|3